A rare CYFIP1 deletion was found in a patient with PDD-NOS and mild intellectual disability (Leblond et al., 2012).
Molecular Function
Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit is an adapter between EIF4E and FMR1. Promotes the translation repression activity of FMR1 in brain probably by mediating its association with EIF4E and mRNA. Regulates formation of membrane ruffles and lamellipodia. Plays a role in axon outgrowth. Binds to F-actin but not to RNA. Part of the WAVE complex that regulates actin filament reorganization via its interaction with the Arp2/3 complex. Actin remodeling activity is regulated by RAC1. Regulator of epithelial morphogenesis. May act as an invasion suppressor in cancers.
External Links
References
Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.
Haploinsufficiency of the schizophrenia and autism risk gene Cyfip1 causes abnormal postnatal hippocampal neurogenesis through microglial and Arp2/3 mediated actin dependent mechanisms
2147 trios with probands diagnosed with ASD and a subset of 1266 trios with probands diagnosed with classical autism from the Autism Genome Project (AGP)
2147 trios with probands diagnosed with ASD and a subset of 1266 trios with probands diagnosed with classical autism from the Autism Genome Project (AGP)
2147 trios with probands diagnosed with ASD and a subset of 1266 trios with probands diagnosed with classical autism from the Autism Genome Project (AGP)
The transgenic mice expressing Cyfip1 transgene, leading to increased production of the protein have increased mature dendritic spines and dendritic spine density.
References
Type
Title
Author, Year
Primary
Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.
Model Type:
Genetic
Model Genotype:
Transgenic
Mutation:
Two transgenic strains (strain nos. 8 and 24) of second and third generation mice harboring a Cyfip1 spanning BAC clone generated by microinjection into fertilized C57BL/6 pronuclei, and showing a 1.5 and 2 fold increase in protein levels respectively (Fig 2E, F) in the adult hippocampus and a ~1.5 fold increase in cyfip1 transcript levels in strain number 8 in the E15 frontal cortex, P1 cerebellum, P11 hippocampus, and in adult frontal cortex and cerebellum (Fig S3).
Allele Type: Overexpression
Strain of Origin: C57BL/6
Genetic Background: C57BL/6
ES Cell Line: Mutant ES Cell Line: Model Source: UCLA transgenic core
Model Type:
Genetic
Model Genotype:
Heterozygous
Mutation:
Cyfip1 heterozygous knockouts were generated by the insertion of the L1L2_Bact_P targeting vector containing FRT, lacz, loxP, a second FRT and a second loxP site at position 55873080, and a third loxp site is intserted at position 55875575 downstream of the targeted exons on chromosome 7. Flp recombinase expression followed by Cre expression creates a floxed followed by a KO mouse. Cyfip1 tet mice are crossed with Tg(Thy1-EGFP)MJrs/J (JAX:00778851) to obtain reporter tagged Thy1-EGFP-Cyfip1-Het mice.
Allele Type: Knockout
Strain of Origin: C57BL/6N-A^tm1Brd
Genetic Background: C57Bl/6
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Not specified
Description: Cyfip1 mutant mice exhibited an increase in the number of NRXN1 puncta throughout the dendritic and somatic compartments of Purkinje cells compared to wildtype controls. Analysis of NRXN1 localization was restricted to proximal branches of the primary dendrite.
Exp Paradigm: Calbindin, a protein expressed throughout the dendritic and somatic compartments of Purkinje cells
Description: Cyfip1 mutant mice exhibited significantly enhanced CYFIP1 protein in the cerebellum compared to wildtype controls.
Exp Paradigm: cerebellum
Description: Mutants show a decrease in cyfip1 protein expression in the motor and frontal cortices and in the hippocampus compared with controls.
Exp Paradigm: NA